Health Management

Education is a significant element of comprehensive care for COPD patients. In this Q&A, one expert shares her recommendations.

The CVS Health-Aetna potential merger will have healthcare executives rethinking traditional industry competitors. Here’s why.

Finding technology solutions to diagnose and manage chronic conditions is critical to the future of healthcare.

While targeted cancer therapies make up a big part of the pipeline, there are three areas that oncology experts want you to keep on your radar.

Analysis from RAND helps frame the potential of biosimilars to reduce spending on biologics.

New data from CMS show that ACOs succeed at producing quality gains and cost savings, but at least one effort begs to differ.

Find out what worked for this value-based physician and hospital network and Accountable Care Organization in Massachusetts.

How can we as an industry help address the growing need and demand for quality mental health services? One of the more promising solutions is the expanded use of certified physician assistants.

Key takeaways for healthcare executives from Bruno Medeiros, MD, associate professor of medicine (hematology) at the Stanford University Medical Center and director of Cancer Center Infusion Area Treatment Services at Stanford Cancer Center.

An Epstein Becker Green survey has surprising results about the expansion of telehealth services physicians and other behavioral health professionals can provide.

One study seeks to understand the underlying causes of racial and ethnic disparities in cancer survival. The results may be surprising.

The success of any value-based care model depends on achieving a strong relationship with members. Here’s three ways how.

A new study has unbelievable findings about treating Medicare patients with diabetes.

A Robert Wood Johnson Foundation expert analyzes the Altarum Institute’s study on healthcare growth findings.

As genomics continues to evolve, here are five things to know about genetic testing and counseling.

A survey explores how physicians perceive their role in the healthcare system, and the findings aren’t good.

A Physicians Foundation survey gives healthcare executives behind the scenes insight into the physician-patient relationship.

With the high efficacy and dire diagnosis, there will be demand for both Kymriah and Yescarta. Here’s how to manage the monetary impact.

New Yale University research offers stunning findings about drug formulary coverage and prescribing opioids.

One expert says incentive programs to motivate physicians miss the mark. Here’s what he recommends instead.

As the healthcare system shifts from a focus on employee-based plans to consumer-based plans, insurers have to find new ways to engage and motivate members.

Providers are coming up short when it comes to HEDIS measures related to substance abuse. Here’s how one health plan is changing that.

Avalere Health analysis has intriguing results about beneficiaries enrolled in diabetes-focused chronic condition special needs plans.

The FDA pushes back on new painkiller’s abuse-deterrent claims. Here’s why this is important to the opioid epidemic.

Acute myeloid leukemia experts share promising new developments on the oncology horizon.

A new study uses population health analytics to identify potential opioid abuse, and the study findings are troubling.

Recent study findings reveal which patients are more likely to be readmitted for COPD problems, and which readmission reduction strategies might work best.

To succeed as a Next Generation ACO, Indiana University Health system is changing its COPD care management approach.

An eye-opening Canadian study has surprising findings about the risk of death and antidepressants.

Avalere conducted an analysis to assess the effect of MIPS. Here are the surprising results.